Biobanks: Market Research Report

September 2011 | 532 pages | ID: BF03E4B267AEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Biobanks in US$ Million.

The report provides separate comprehensive analytics for the US, Europe, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

Also, a six-year historic analysis is provided for these markets.

The report profiles 251 companies including many key and niche players such as Service Providers - Asterand PLC, CBR Systems, Inc., Cord Blood America, Inc., Cryo-Cell International, Inc., Cryo-Save Group NV, LifebankUSA, Tissue Solutions Ltd., ViaCord, and Vita 34 AG.

The report also profiles Resources & Equipment Suppliers/ Manufacturers such as BioKryo GmbH, GenVault, Hamilton Storage Technologies, LABVANTAGE Solutions, Inc., NEXUS Biosystems, REMP AG, Qiagen NV, TAP Biosystems, ThemoGenesis, and Thermo Scientific.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

2.INDUSTRY OVERVIEW

Outlook for Global Biobanking Industry
Global Biobanking Trends
Pharma and Biotech Companies Increasingly Outsource Biobanking
Research-based Biobanks Continue to Dominate Industry
Umbrella Organizations Initiated for Coordinating Research Biobanks
Advanced Technology Employed for Sample Storage
Potential for Expansion of Commercial Biobanks in Tissue Banking Market
Ethical and Legal Issues Concerning Biobanking
Challenges Confronting Global Biobanking

3.STEM CELL BANKING – AN OVERVIEW

Stem Cell Banking – An Outlook
Key Players in Stem Cell Banking Market

Table 1. Global Market for Stem Cell Banking (2010): Percentage Share Breakdown by Major Players – ViaCell, Cryo-Cell, Osiris Therapeutics, Geron Corporation, Cytori Therapeutics, International Stem Cell Corporation, Arthersys and Others (includes corresponding Graph/Chart)

Service Overview
Introduction to Stem Cells
Types of Stem Cells Banked
Haematopoietic Stem Cells (HSC)
Mesenchymal Stem Cells (MSC)

4.CORD BLOOD BANKING – AN OVERVIEW

Current State of Cord Blood Banking Market
Major Cord Blood Banking Trends
Charges of Services and Products Vary Across Markets
Cord Blood Biobanks Adopt New Storage Technologies
Ethical and Legal Aspects of Cord Blood Markets
Regional Overview
The United States
Europe
Asia-Pacific
Latin America
Cord Blood Versus Bone Marrow Stem Cells
Advantages of Cord Blood over Bone Marrow in Transplantation
Ease of Procurement of Cord Blood Stem Cells
Disadvantages of Cord Blood Stem Cells Over Bone Marrow
Private Cord Blood Banks Versus Public Banks
Regulation and Quality Assurance
Ownership of Donated Sample
Commercialization and Patenting
Opportunities and Threats Facing Cord Blood Banking
Service Overview
Introduction to Cord Blood Banking
Applications of Cord Blood Banking in Treatment of Diseases
Advantages of Cord Blood Banking Over Embryonic Stem Cell Banking
Private and Public Cord Blood Banks

Table 2. Worldwide Distribution of Private Cord Blood Banks (2010): Breakdown by Leading Geographic Regions Ranked by Number of Operating Private Banks (includes corresponding Graph/Chart)

5.SERVICE OVERVIEW OF BIOBANKING

Introduction to Biobanking
Various Biobanking Processes
Classification of Biobanks
Classification of Human Biobanks Based on Various Factors
Various Functions of Biobanks
Applications of Biobanks in Diverse Fields of Study
Biobanking Equipment and Automation Systems
Major Types of Biobanking Equipment
Ultra Low Temperature Freezer
Automated Liquid Handling Systems
Laboratory Information Management Systems

6.SERVICE/PRODUCT INTRODUCTIONS

Tran-Scell Biologics to Initiate Stem Cell Bank in Hyderabad
ViaCord Introduces Umbilical Cord Tissue Stem Cells Storage
WHEATON Launches KeepIT Freezer Box for Biobanking
Provia Laboratories Introduces Proviasette™ Biosample Storage Cassettes
Bluechiip and STMicroelectronics to Introduce Tracking Tags
RainDance to Introduce DeepSeqTM FFPE Solution for Discovering Rare Cancer Mutations
Desmon Expands Range of Ultra Low Temperature Freezers for Biobanks
Exiqon Launches GLP Compliant Services for miRNA Biomarker Screening
Cryo-Cell International to Introduce Cryology RTS® Reproductive Tissue Storage Service
NGC Medical and Bio Serve Establish BioServe-Europe
Covance Opens Advanced Biorepository Facility
Vanderbilt University Opens DNA Biobank
Estonian Genome Center to Open Biorepository
Biomatrica Introduces Biomatrica Connect™
Thermo Fisher Scientific Introduces Biospecimen and Biobanking Management Software Solution
Aurora Opens Robotic Biorepository and Informatics Technology Databank
LABVANTAGE Launches 90 Day at US$ 90,000 Biobanking Solution

7.RECENT INDUSTRY ACTIVITY

Cord Blood America Acquires UCB Samples and Laboratory Equipment from RGI
Cord Blood America Inks Supply Agreement with Tissue and Cell Bank
Cord Blood America Acquires Minority Stake in Stem Cells VIDAPLUS
Kaiser Permanente Center to Begin US$100,000 Specimen Collection at NW Biobank
Finland Invests in Biomedinfra to Develop Biobanking, Bioinformatics, Biomedical Infrastructure
ViaCord Unveils New Umbilical Cord Blood Stem Cell Unit
Tissue Solutions Gains Approval for Ethical Biobanking of Psoriasis Skin Samples
Integrated BioBank of Luxembourg Inks Agreement with WaferGen Biosystems
LifeTechnologies Signs Strategic Partnership Agreement with IBBL
Air Liquide Healthcare Acquires Pacific Science
Cogenics Collaborates with SinoGenoMax for Clinical Genotyping in China
Novo Nordisk Foundation to Establish Danish Biobank
EU to Offer Cross-Border Tax Breaks for Biobanking
Gentel Biosciences to Provide Assays for SCOPE Study’s Pregnancy Biobank
CordLife Announces Plans for Expanding Operations in India, China
deCODE Genetics Divests Islensk Erfdagreining to Saga Investments LLC
Cord Blood Bank, Cryo-Save Forays Into Indian Market
HUNT Biobank to Deploy Thermo Fisher Scientific’s LIMS for Norway Health Studies
HIV Vaccine Trials Network to Deploy BARC’s Biobanking in South Africa

8.FOCUS ON SELECT GLOBAL PLAYERS

Biobank Service Providers
Asterand PLC (US)
CBR Systems, Inc (US)
Cord Blood America, Inc. (US)
Cryo-Cell International, Inc. (US)
Cryo-Save Group NV (The Netherlands)
LifebankUSA (US)
Tissue Solutions Ltd (UK)
ViaCord (US)
Vita 34 AG (Germany)
Biobank Resources & Equipment Suppliers/ Manufacturers
BioKryo GmbH (Germany)
GenVault (US)
Hamilton Storage Technologies (US)
LABVANTAGE Solutions, Inc. (US)
NEXUS Biosystems (US)
REMP AG (Switzerland)
Qiagen NV (The Netherlands)
TAP Biosystems (UK)
ThemoGenesis (US)
Thermo Scientific (US)

9.GLOBAL MARKET PERSPECTIVE

Table 3. World Recent Past, Current and Future Analysis for Biobank Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 4. World Historic Review for Biobank Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

10.THE UNITED STATES

A. MARKET ANALYSIS

Outlook
Biobanking in the US – Ethical and Legal Aspects
US Pioneering the Global Cord Blood Banking Market
Research-based Biobanks in the US
Product/Service Introductions
Recent Industry Activity
Key Players

B. MARKET ANALYTICS

Table 5. US Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 6. US Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11.EUROPE

A. MARKET ANALYSIS

Outlook
EU to Offer Cross-Border Tax Breaks for Biobanking
Overview of European Research-based Biobanking
Ownership of Research-based Biobanks

Table 7. European Research-based Biobanks (2010): Percentage Share Breakdown by Biobank Ownership Types -National or Regional Agencies, Universities, Non-profit Organizations and Private Organizations (includes corresponding Graph/Chart)

Purpose and Scale of Operations

Table 8. European Research-based Biobanks (2010): Percentage Breakdown by Major Purpose Types (includes corresponding Graph/Chart)

Table 9. European Research-based Biobanks (2010): Percentage Breakdown by Major Research Formats – Public Research, Public and Clinical Research, Clinical Research, Multiple Format Research and Others (includes corresponding Graph/Chart)

Table 10. Research-based Biobanks in Europe (2010): Percentage Breakdown of Biobank Categories Based on Scale of Operation (includes corresponding Graph/Chart)

Data and Sample Collection
Ethics and Sharing of Biosamples
Legal Aspects

B. MARKET ANALYTICS

Table 11. European Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 12. European Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11A.FRANCE

A. MARKET ANALYSIS

Outlook
Research-based Biobanks

B. MARKET ANALYTICS

Table 13. French Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 14. French Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11B.GERMANY

A. MARKET ANALYSIS

Outlook
Research-based Biobanks in Germany
Overview of Biobank Structure in Germany – Major Research Biobanks, Hospital-Affiliated Biobanks and Private Cord Blood Banks
Key Players

B. MARKET ANALYTICS

Table 15. German Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 16. German Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11C.ITALY

A. MARKET ANALYSIS

Outlook
Research-based Biobanks
Product/Service Introductions

B. MARKET ANALYTICS

Table 17. Italian Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 18. Italian Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11D.THE UNITED KINGDOM

A. MARKET ANALYSIS

Outlook
Research-based Biobanks in the UK
The UK Biobank
Product/Service Introduction
Key Players

B. MARKET ANALYTICS

Table 19. UK Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 20. UK Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11E.THE NETHERLANDS

A. MARKET ANALYSIS

Outlook
Research-based Biobanks
Key Players

B. MARKET ANALYTICS

Table 21. Dutch Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 22. Dutch Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

11F.REST OF EUROPE

A. MARKET ANALYSIS

Outlook
Research Based Biobanks - Focus on Select Regions
Sweden
Norway
Denmark
Finland
Iceland
deCODE Genetics
Estonia
Estonian Genome Project
Product/Service Introductions
Recent Industry Activity
Key Player

B. MARKET ANALYTICS

Table 23. Rest of Europe Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 24. Rest of Europe Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

12.REST OF WORLD

A. MARKET ANALYSIS

Outlook
Research-Based Biobanks - Focus on Select Regional Markets
Canada
Asia-Pacific
Japan
China
Chinese Cord Blood Banking Markets Offer High Growth Potential
India
Cord Blood Banking in India Poised for a Significant Growth
Enhanced Cord Blood Banking Fuels Medical Tourism in India
Singapore
Australia
Taiwan
South Korea
Latin America
Mexico
Service/Product Introduction
Recent Industry Activity
Key Player

B. MARKET ANALYTICS

Table 25. Rest of World Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 26. Rest of World Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Competitive Landscape
Total Companies Profiled: 251 (including Divisions/Subsidiaries - 262)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Africa
Middle East